Seoul, South Korea

Hyerim Ga


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyerim Ga: Innovator in Chiral Chemistry from Seoul

Introduction

Hyerim Ga, a notable inventor based in Seoul, South Korea, has made significant contributions to the field of chiral chemistry. With a focus on the development of enantiomerically pure compounds, he is at the forefront of innovative research that holds potential implications for various applications in chemical synthesis.

Latest Patents

Hyerim Ga holds a patent for "Enantiomerically pure binaphthol derivatives and method for preparing the same." This invention pertains to unique compounds, specifically the S-enantiomer and R-enantiomer binaphthol derivatives, which serve as crucial intermediates in the production of 2,2'-binaphthol-3-aldehyde derivatives. The method he has developed for synthesizing these compounds is both cost-effective and safe, enhancing the overall efficiency of chemical fabrication.

Career Highlights

Currently, Hyerim Ga is employed at Aminologics Co., Ltd., where his expertise in enantiomerically pure compounds plays a pivotal role in the company's research objectives. His contributions to the field have established him as a key figure within his organization, driving forward innovations that align with the needs of the industry.

Collaborations

Hyerim collaborates with talented coworkers, including Rae Kyu Chang and Yun Soo Ahn, within Aminologics Co., Ltd. Their teamwork fosters a creative and innovative environment, enabling them to explore new horizons in chiral chemistry and contribute collectively to advancements in their field.

Conclusion

Hyerim Ga exemplifies the spirit of innovation with his dedicated research and development of enantiomerically pure compounds. His patent signifies not only a personal achievement but also a leap forward in the field of synthetic chemistry. As he continues his work at Aminologics Co., Ltd., he is poised to make further advancements that could potentially benefit a wide range of chemical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…